Answer
Yes, selexipag is contraindicated in patients who have had a myocardial infarction within the last six months.
Sources for this answer
- Uptravi 200 microgram film-coated tablets (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 19Document updated
Sources checked